MARK2 and early-onset autosomal dominant Alzheimer disease: How to cite this article: Sun, W. et al. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.